Volver a Agenda
Session 5: AI in Ad Promo: Transforming Marketing While Navigating Compliance
Session Chair(s)
Georgina Lee, PharmD
Executive Director, Regulatory Advertising and Promotion
Sage Therapeutics, United States
Virginia Foley
VP Regulatory, Life Sciences & Healthcare
Constellation, Inc., United States
Zoe Dunn
President & CEO
Hale Advisors, Inc., United States
Discover the future of advertising as AI reshapes consumer engagement. In this session, we’ll dive into the power of Machine Learning, Large Language Models, and Generative AI to create dynamic, data-driven content that captivates audiences and drives brand loyalty. Uncover how marketing teams are transforming their strategies, building trust, and meeting industry standards with unprecedented speed and precision. Plus, learn how brands are leveraging a strong digital presence to shape their narrative across platforms—and how cutting-edge AI tools are combating misinformation to safeguard message accuracy and brand reputation.
Learning Objective : - Demonstrate a deeper understanding of artificial intelligence and its impact on Advertising and Promotion
- Recognize how and why marketing teams need to use AI
- Explain the unique obligations and requirements when using GenAI to engage with consumers and HCPs
Speaker(s)
AL Considerations – Legal Perspective
Dara S. Katcher Levy, JD
Hyman Phelps & McNamara P.C., United States
Director
A Tale of Three Rhymes
Nazeer Ahmed, MS
Allergan, United States
Associate Director (acting) for MLRC
Panel Presentation
Vera Kutsenko
Artrix Ai, United States
CEO
Speaker
Georgia Gayle, MBA, PMP
Alexion, Astrazeneca Rare Disease, United States
Director, Head of Promotional Review and Operations (PRO)
¿Tiene una cuenta?